Conference Coverage

Three days of beta-lactam beat clinically stable CAP


 

REPORTING FROM ECCMID 2018

Nor does Dr. Dinh expect wholesale clinical embracing of the encouraging results, which bolster the ever-accumulating data in favor of shorter courses of antibiotics for some infectious diseases.

“I think there is a chance that clinicians who normally treat for 9 or 10 days may now feel comfortable reducing to 7,” he said with a chuckle.

The French Ministry of Health sponsored the study. Dr. Dinh had no competing financial interests.

SOURCE: Dinh et al. ECCMID 2018, Oral Abstract O1126.

Pages

Next Article:

FDA warns against clarithromycin use in patients with heart disease